Swiss National Bank’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Swiss National Bank’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-85,700	Closed	-$1.83M	–	2531
2024 Q1	$1.83M	Buy	+85,700	New	+$1.03M	﹤0.01%	1883

Swiss National Bank's FUSN Position: Q2 2024 in Review

Swiss National Bank sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 85,700 shares — an estimated $1.83M sold.

Swiss National Bank first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $1.83M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Swiss National Bank reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Swiss National Bank sold 85,700 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $1.83M.
Swiss National Bank first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
Swiss National Bank's Fusion Pharmaceuticals Inc. Common Shares position peaked at $1.83M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Swiss National Bank's 13F filing for Q2 2024, filed 8 Aug 2024.